A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia.
- Authors:
- S Lheureux, M Cabanero, MC Cristea, G Mantia-Smaldone, A Olawaiye, S Ellard, JI Weberpals, AEW Hendrickson, GF Fleming, S Welch, NC Dhani, A Piskorz, S Tan, K Chang, L Wang, C Kunos, TJ Pugh, JD Brenton, AM Oza
- Journal:
- JOURNAL OF CLINICAL ONCOLOGY
- Citation info:
- 37(15)
- Publication date:
- 1st Aug 2019
- Full text
- DOI